Structure	Catalog	Product Name	CAS	E3 Ligase	Target	Inquiry
	BPL-201073	WH174		VHL	HDAC6	Inquiry
Molecular Weight: 951.16 Molecular Formula: C49H62N10O8S Description: It is a multifunctional histone deacetylase 6 (HDAC6) degrader with potent antimyeloma activity.
	BPL-201074	WH167		VHL	HDAC6	Inquiry
Molecular Weight: 965.19 Molecular Formula: C50H64N10O8S Description: It is a multifunctional histone deacetylase 6 (HDAC6) degrader with potent antimyeloma activity.
	BPL-201075	WH221		VHL	HDAC6	Inquiry
Molecular Weight: 1009.24 Molecular Formula: C52H68N10O9S Description: It is a multifunctional histone deacetylase 6 (HDAC6) degrader with potent antimyeloma activity.
	BPL-201076	WH212		VHL	HDAC6	Inquiry
Molecular Weight: 1053.29 Molecular Formula: C54H72N10O10S Description: It is a multifunctional histone deacetylase 6 (HDAC6) degrader with potent antimyeloma activity.
	BPL-201077	2-(4-(2-(N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-N-(8-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)octyl)acetamide	2097971-03-2	CRBN	BRD9	Inquiry
Molecular Weight: 960.09 Molecular Formula: C46H53N7O12S2 Density: 1.49±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201078	2-(4-(2-(N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-N-(1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-2-oxo-7,10,13-trioxa-3-azahexadecan-16-yl)acetamide	2097971-06-5	CRBN	BRD9	Inquiry
Molecular Weight: 1036.15 Molecular Formula: C48H57N7O15S2 Density: 1.49±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201079	2-(4-(2-(N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-N-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)hexyl)acetamide	2097971-07-6	CRBN	BRD9	Inquiry
Molecular Weight: 874.98 Molecular Formula: C42H46N6O11S2 Density: 1.52±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201080	N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-7-(4-(2-(1'-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetyl)-[4,4'-bipiperidin]-1-yl)-2-oxoethoxy)-3-methoxyphenyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridine-2-carboximidamide	2097509-52-7	CRBN	BRD9	Inquiry
Molecular Weight: 984.12 Molecular Formula: C48H53N7O12S2 Density: 1.56±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201081	(2S,4R)-1-((S)-2-(tert-Butyl)-17-(4-(2-(N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-4,16-dioxo-6,9,12-trioxa-3,15-diazaheptadecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	2097971-09-8	VHL	BRD9	Inquiry
Molecular Weight: 1121.37 Molecular Formula: C53H68N8O13S3 Density: 1.42±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201082	(2S,4R)-1-((S)-2-(tert-Butyl)-14-(4-(2-(N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-4,13-dioxo-6,9-dioxa-3,12-diazatetradecanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	2097971-15-6	VHL	BRD9	Inquiry
Molecular Weight: 1077.32 Molecular Formula: C51H64N8O12S3 Density: 1.43±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201083	2-(4-(2-(N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-N-(8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)octyl)acetamide	2097509-23-2	CRBN	BRD9	Inquiry
Molecular Weight: 902.07 Molecular Formula: C44H51N7O10S2 Density: 1.48±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201084	2-(4-(2-(N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-N-(8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)octyl)acetamide	2097509-46-9	CRBN	BRD9	Inquiry
Molecular Weight: 902.07 Molecular Formula: C44H51N7O10S2 Density: 1.48±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201085	2-(4-(2-(N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)carbamimidoyl)-5-methyl-4-oxo-4,5-dihydrothieno[3,2-c]pyridin-7-yl)-2-methoxyphenoxy)-N-(8-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)amino)octyl)acetamide	2097509-20-9	CRBN	BRD4 BRD7 BRD9	Inquiry
Molecular Weight: 888.08 Molecular Formula: C44H53N7O9S2 Density: 1.45±0.1 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201086	2-((2,6-Dimethoxy-4-(2-methyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)benzyl)(methyl)amino)-N-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)hexyl)acetamide	2170679-40-8	CRBN	BRD9	Inquiry
Molecular Weight: 751.84 Molecular Formula: C40H45N7O8 Boiling Point: 997.9±65.0°C at 760 Torr Density: 1.331±0.06 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201087	2-((2,6-Dimethoxy-4-(2-methyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)benzyl)(methyl)amino)-N-(8-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)amino)octyl)acetamide		CRBN	BRD9	Inquiry
Molecular Weight: 765.91 Molecular Formula: C42H51N7O7 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201088	(2S,4R)-1-((S)-18-(tert-Butyl)-1-(2,6-dimethoxy-4-(2-methyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)phenyl)-2-methyl-4,16-dioxo-8,11,14-trioxa-2,5,17-triazanonadecan-19-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide		VHL	BRD9	Inquiry
Molecular Weight: 999.20 Molecular Formula: C51H66N8O11S Boiling Point: 1159.5±65.0°C at 760 Torr Density: 1.268±0.06 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201089	2-((2,6-Dimethoxy-4-(2-methyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)benzyl)(methyl)amino)-N-(8-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)octyl)acetamide	2170679-44-2	CRBN	BRD9	Inquiry
Molecular Weight: 837.93 Molecular Formula: C44H51N7O10 Boiling Point: 1075.9±65.0°C at 760 Torr Density: 1.306±0.06 g/cm3 Description: It is a PROTAC that can degrade the BAF complex factor BRD9 by heterobifunctional ligand.
	BPL-201090	(S)-2-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutanamido)-4-methyl-N-(2-(2-(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)ethoxy)ethoxy)ethyl)pentanamide	2133321-59-0	cIAP1	Htt	Inquiry
Molecular Weight: 661.87 Molecular Formula: C36H47N5O5S Density: 1.219±0.06 g/cm3 Description: It can induce the degradation of huntingtin (Htt) and reduce mHtt levels in HD patient fibroblasts.
	BPL-201091	(S)-2-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutanamido)-N-(2-(2-(2-((2-((E)-(4-(dimethylamino)phenyl)diazenyl)benzo[d]thiazol-6-yl)oxy)ethoxy)ethoxy)ethyl)-4-methylpentanamide	2766855-40-5	cIAP1	Htt	Inquiry
Molecular Weight: 719.91 Molecular Formula: C37H49N7O6S Density: 1.27±0.1 g/cm3 Description: It can induce the degradation of huntingtin (Htt) and reduce mHtt levels in HD patient fibroblasts.
	BPL-201092	TMX-1117	2488752-67-4	CRBN	CDK2	Inquiry
Molecular Weight: 887.75 Molecular Formula: C36H40BrFN10O9S Density: 1.65±0.1 g/cm3 Description: It is a heterobifunctional CDK2 degrader.

PROTAC Library